Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other smid-cap ...

As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

adidas Originals has paired with Edison Chen's streetwear label CLOT for another collaboration. The duo unveiled the Lunar New Year collection that proudly represents Chinese culture with a modern ...

Inari’s portfolio of medical devices and accessories to treat venous thromboembolism (VTE), or blood clots in the veins, was highly attractive to Stryker, according to Inari Chief Executive Drew Hykes ...

Inari Medical Inc. (NASDAQ ... and other venous diseases through clot removal without the use of thrombolytic drugs. Each year, VTE impacts nearly one million lives in the United States, mostly ...